Labcorp Surges to 166th in Trading Volume with $646 Million Day

On July 24, 2025, Labcorp's trading volume reached $646 million, marking a 93.68% increase from the previous day. This surge placed Labcorp at the 166th position in terms of trading volume for the day. The company's stock price also saw a notable increase of 6.86%.

Labcorp's strong performance in the second quarter of 2025 was driven by robust revenue growth across its key divisions. The company's diagnostic lab unit reported an 8.9% increase in revenue, reaching $2.75 billion. Similarly, its contract research business saw an 11% rise, generating $784.8 million in revenue. These figures highlight the company's ability to capitalize on growing demand for diagnostic services and contract research.

During the second quarter of 2025, Labcorp reported earnings of $4.35 per share, surpassing the consensus estimate of $4.14 per share. This represents a 10.4% year-over-year increase in earnings per share. The company's revenue for the quarter was $3.53 billion, a 9.5% increase from the same period last year. This strong financial performance has positioned Labcorp favorably in the medical services industry.

Labcorp has also revised its full-year financial projections, anticipating revenue growth between 7.5% and 8.6%. This adjustment reflects the company's confidence in its ability to maintain strong performance throughout the year. The revised projections indicate a positive outlook for Labcorp's financial health and its potential for continued growth.